Search

Sean E. Aeder

Examiner (ID: 17479)

Most Active Art Unit
1642
Art Unit(s)
1642
Total Applications
1933
Issued Applications
905
Pending Applications
202
Abandoned Applications
853

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18377237 [patent_doc_number] => 20230152324 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-18 [patent_title] => TUMOR-INTRINSIC NLRP3 INFLAMMASOME SIGNALING PATHWAY AS A GENETIC AND FUNCTIONAL BIOMARKER FOR IMMUNOTHERAPY RESPONSE [patent_app_type] => utility [patent_app_number] => 18/055406 [patent_app_country] => US [patent_app_date] => 2022-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19552 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18055406 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/055406
TUMOR-INTRINSIC NLRP3 INFLAMMASOME SIGNALING PATHWAY AS A GENETIC AND FUNCTIONAL BIOMARKER FOR IMMUNOTHERAPY RESPONSE Nov 13, 2022 Abandoned
Array ( [id] => 18565752 [patent_doc_number] => 20230256079 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-17 [patent_title] => ONCOLYTIC VIRUS VACCINE AND DRUG FOR TREATING TUMORS BY COMBINING ONCOLYTIC VIRUS VACCINE WITH IMMUNE CELLS [patent_app_type] => utility [patent_app_number] => 18/054597 [patent_app_country] => US [patent_app_date] => 2022-11-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11985 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18054597 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/054597
Oncolytic virus vaccine and drug for treating tumors by combining oncolytic virus vaccine with immune cells Nov 10, 2022 Issued
Array ( [id] => 18693991 [patent_doc_number] => 20230324394 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-12 [patent_title] => METHODS FOR THE DETECTION AND TREATMENT OF PANCREATIC DUCTAL ADENOCARCINOMA [patent_app_type] => utility [patent_app_number] => 18/054307 [patent_app_country] => US [patent_app_date] => 2022-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22391 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18054307 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/054307
METHODS FOR THE DETECTION AND TREATMENT OF PANCREATIC DUCTAL ADENOCARCINOMA Nov 9, 2022 Pending
Array ( [id] => 19608903 [patent_doc_number] => 12157769 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-12-03 [patent_title] => Virus composition [patent_app_type] => utility [patent_app_number] => 18/047285 [patent_app_country] => US [patent_app_date] => 2022-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 18 [patent_no_of_words] => 4693 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18047285 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/047285
Virus composition Oct 17, 2022 Issued
Array ( [id] => 18325137 [patent_doc_number] => 20230123265 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-04-20 [patent_title] => N6-Methyladenosine Regulators in Uterine Fibroids [patent_app_type] => utility [patent_app_number] => 17/968386 [patent_app_country] => US [patent_app_date] => 2022-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4320 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17968386 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/968386
N6-Methyladenosine Regulators in Uterine Fibroids Oct 17, 2022 Pending
Array ( [id] => 18649488 [patent_doc_number] => 20230295302 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-21 [patent_title] => METHODS OF TREATING TUMOR [patent_app_type] => utility [patent_app_number] => 18/047216 [patent_app_country] => US [patent_app_date] => 2022-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37644 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18047216 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/047216
Methods of treating tumor Oct 16, 2022 Issued
Array ( [id] => 18256164 [patent_doc_number] => 20230083203 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-16 [patent_title] => NON-INVASIVE TEST TO PREDICT RESPONSE TO THERAPY IN COLORECTAL CANCER PATIENTS [patent_app_type] => utility [patent_app_number] => 18/046565 [patent_app_country] => US [patent_app_date] => 2022-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3960 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18046565 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/046565
NON-INVASIVE TEST TO PREDICT RESPONSE TO THERAPY IN COLORECTAL CANCER PATIENTS Oct 13, 2022 Abandoned
Array ( [id] => 18988166 [patent_doc_number] => 20240060135 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-02-22 [patent_title] => THERAPEUTIC AND DIAGNOSTIC METHODS FOR CANCER [patent_app_type] => utility [patent_app_number] => 17/937102 [patent_app_country] => US [patent_app_date] => 2022-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 132800 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17937102 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/937102
THERAPEUTIC AND DIAGNOSTIC METHODS FOR CANCER Sep 29, 2022 Abandoned
Array ( [id] => 18198470 [patent_doc_number] => 20230051989 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-02-16 [patent_title] => CHIMERIC ANTIGEN RECEPTOR AND METHODS OF USE THEREOF [patent_app_type] => utility [patent_app_number] => 17/932259 [patent_app_country] => US [patent_app_date] => 2022-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24290 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17932259 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/932259
Chimeric antigen receptor and methods of use thereof Sep 13, 2022 Issued
Array ( [id] => 19426162 [patent_doc_number] => 12085569 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-09-10 [patent_title] => Plasma autoantibody biomarkers for basal like breast cancer [patent_app_type] => utility [patent_app_number] => 17/940883 [patent_app_country] => US [patent_app_date] => 2022-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2259 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17940883 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/940883
Plasma autoantibody biomarkers for basal like breast cancer Sep 7, 2022 Issued
Array ( [id] => 18421597 [patent_doc_number] => 20230176061 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-08 [patent_title] => METHODS FOR DIAGNOSING HIGH-RISK CANCER USING POLYSIALIC ACID AND ONE OR MORE TISSUE-SPECIFIC BIOMARKERS [patent_app_type] => utility [patent_app_number] => 17/884465 [patent_app_country] => US [patent_app_date] => 2022-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25546 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17884465 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/884465
METHODS FOR DIAGNOSING HIGH-RISK CANCER USING POLYSIALIC ACID AND ONE OR MORE TISSUE-SPECIFIC BIOMARKERS Aug 8, 2022 Pending
Array ( [id] => 18666282 [patent_doc_number] => 11773160 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2023-10-03 [patent_title] => Immune-stimulating IL-2 fusion proteins [patent_app_type] => utility [patent_app_number] => 17/817886 [patent_app_country] => US [patent_app_date] => 2022-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 24684 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 128 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17817886 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/817886
Immune-stimulating IL-2 fusion proteins Aug 4, 2022 Issued
17/817862 DOSING FOR TREATMENT WITH ANTI-CD20/ANTI-CD3 BISPECIFIC ANTIBODIES Aug 4, 2022 Abandoned
Array ( [id] => 18737950 [patent_doc_number] => 20230346852 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-02 [patent_title] => APPLICATION OF BACTERIA IN PREPARATION OF SYNERGIST FOR IMMUNE CHECKPOINT INHIBITOR [patent_app_type] => utility [patent_app_number] => 18/025640 [patent_app_country] => US [patent_app_date] => 2022-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13692 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18025640 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/025640
Application of bacteria in preparation of synergist for immune checkpoint inhibitor Jul 11, 2022 Issued
Array ( [id] => 18077433 [patent_doc_number] => 20220403045 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-12-22 [patent_title] => RECOMBINANT MONOCLONAL ANTIBODIES AND CORRESPONDING ANTIGENS FOR COLON AND PANCREATIC CANCERS [patent_app_type] => utility [patent_app_number] => 17/848694 [patent_app_country] => US [patent_app_date] => 2022-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26648 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17848694 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/848694
Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers Jun 23, 2022 Issued
Array ( [id] => 19246801 [patent_doc_number] => 20240197785 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-06-20 [patent_title] => PROCESSING OF TUMOR INFILTRATING LYMPHOCYTES [patent_app_type] => utility [patent_app_number] => 18/573111 [patent_app_country] => US [patent_app_date] => 2022-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 106920 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -48 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18573111 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/573111
PROCESSING OF TUMOR INFILTRATING LYMPHOCYTES Jun 21, 2022 Pending
Array ( [id] => 18110853 [patent_doc_number] => 20230003733 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-01-05 [patent_title] => BIOMARKERS AND USES THEREOF FOR SELECTING IMMUNOTHERAPY INTERVENTION [patent_app_type] => utility [patent_app_number] => 17/846966 [patent_app_country] => US [patent_app_date] => 2022-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26408 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17846966 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/846966
BIOMARKERS AND USES THEREOF FOR SELECTING IMMUNOTHERAPY INTERVENTION Jun 21, 2022 Abandoned
Array ( [id] => 18167865 [patent_doc_number] => 20230034473 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-02-02 [patent_title] => METHODS OF TREATING FIBROBLAST GROWTH FACTOR 19-MEDIATED CANCERS AND TUMORS [patent_app_type] => utility [patent_app_number] => 17/843852 [patent_app_country] => US [patent_app_date] => 2022-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25169 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17843852 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/843852
METHODS OF TREATING FIBROBLAST GROWTH FACTOR 19-MEDIATED CANCERS AND TUMORS Jun 16, 2022 Abandoned
Array ( [id] => 19418522 [patent_doc_number] => 20240294645 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-09-05 [patent_title] => BISPECIFIC FUSION PROTEIN [patent_app_type] => utility [patent_app_number] => 18/570792 [patent_app_country] => US [patent_app_date] => 2022-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13243 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18570792 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/570792
BISPECIFIC FUSION PROTEIN Jun 16, 2022 Pending
Array ( [id] => 20309214 [patent_doc_number] => 20250326843 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-10-23 [patent_title] => BISPECIFIC ANTIBODY COMBINATION AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 18/571174 [patent_app_country] => US [patent_app_date] => 2022-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10545 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18571174 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/571174
BISPECIFIC ANTIBODY COMBINATION AND USE THEREOF Jun 16, 2022 Pending
Menu